[Overview of the clinical reference guides for the idiopathic hematopoietic disorders].
The research committee for idiopathic hematopoietic disorders, which has been supported by the government over the past 35 years, has recently worked out a series of reference guide for the management of diseases under investigation to provide aids for better understanding of pathophysiology of diseases and appropriate clinical decision making. Such attempts covered aplastic anemia, Fanconi anemia, pure red cell aplasia, autoimmune hemolytic anemia, paroxysmal nocturnal hemoglobinuria, myelodysplastic syndromes and primary myelofibrosis, and included diagnostic criteria and severity classification as well as clinical pictures derived from nationwide survey studies. Therapeutic measures were evaluated according to the concepts of evidence-based medicine, when applicable. This report presents an overview of these guides and summarizes key issues in each disease entity.
Omine
Mitsuhiro
M
Showa University Fujigaoka Hospital.
D000741:Anemia, Aplastic; D000743:Anemia, Hemolytic; D000753:Anemia, Refractory / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D005199:Fanconi Anemia; D006801:Humans; D009190:Myelodysplastic Syndromes; D017410:Practice Guidelines as Topic; D055728:Primary Myelofibrosis; D012010:Red-Cell Aplasia, Pure; D012720:Severity of Illness Index